Agfa sells CardioNow

Article

A provider of data management services for clinical trials has purchased CardioNow from Agfa Healthcare.

Agfa sells CardioNow
A provider of data management  services for clinical trials has purchased CardioNow from Agfa Healthcare. With this acquisition, BioClinica plans to add within 45 days the ability to track, share, blindly interpret, and archive medical images for multi-center clinical trials to its services portfolio. Neither the price of the acquisition nor other details regarding the acquisition were publicly released.  Executives at BioClinica expect to integrate CardioNow services  into their portfolio, extending the company’s ability to manage the process that begins after a medical image is acquired as part of a clinical trial. Imaging information will also be integrated with BioClinica Express electronic data capture to simplify and enhance the clinical trial process for life science companies, according to BioClinica.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.